Stability of Commercially Available Glucagon Formulation for Dual-Hormone Artificial Pancreas Clinical Use-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Stability of Commercially Available Glucagon Formulation for Dual-Hormone Artificial Pancreas Clinical Use

Published:2017-10 Issue:10 Volume:19 Page:589-594
ISSN:1520-9156
Container-title:Diabetes Technology & Therapeutics
language:en
Short-container-title:Diabetes Technology & Therapeutics

Author:

Taleb Nadine¹²,Coriati Adèle¹,Khazzaka Christian¹,Bayonne Jonathan¹,Messier Virginie¹,Rabasa-Lhoret Rémi¹³⁴

Affiliation:

1. Institut de recherches cliniques de Montréal, Montréal, Québec, Canada.

2. Division of Biomedical Sciences, Faculty of Medicine, Université de Montréal, Montréal, Québec, Canada.

3. Montreal Diabetes Research Center, Québec, Canada.

4. Department of Nutrition, Faculty of Medicine, Université de Montréal, Montréal, Québec, Canada.

Publisher

Mary Ann Liebert Inc

Subject

Medical Laboratory Technology,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://www.liebertpub.com/doi/pdf/10.1089/dia.2017.0204

Reference26 articles.

1. The role of glucagon in the regulation of plasma lipids

2. Coming of age: the artificial pancreas for type 1 diabetes

3. Outpatient overnight glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or conventional insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, randomised controlled trial

4. Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial

5. Single- and Dual-Hormone Artificial Pancreas for Overnight Glucose Control in Type 1 Diabetes

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stability Determination of Intact Humanin-G with Characterizations of Oxidation and Dimerization Patterns;Biomolecules;2023-03-11

2. Vasodilatory effects of glucagon: A possible new approach to enhanced subcutaneous insulin absorption in artificial pancreas devices;Frontiers in Bioengineering and Biotechnology;2022-09-21

3. A Light Activated Glucagon Trimer with Resistance to Fibrillation;ACS Biomaterials Science & Engineering;2021-03-11

4. Engineering biopharmaceutical formulations to improve diabetes management;Science Translational Medicine;2021-01-27

5. Structural Refinement of Glucagon for Therapeutic Use;Journal of Medicinal Chemistry;2019-11-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3